EUVIMEDEUVIMED entdecken
Crossref

Non‐conditioned cord blood transplantation for infection control in athymic CHARGE syndrome

Motoshi Sonoda, Masataka Ishimura, Hirosuke Inoue, Katsuhide Eguchi, Masayuki Ochiai, Yasunari Sakai, Takehiko Doi, Kyoko Suzuki, Takeshi Inoue, Tomoyuki Mizukami, Kimitoshi Nakamura, Hidetoshi Takada und 1 weitere

Pediatric Blood & Cancer · 2024

DOI: 10.1002/pbc.30809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Motoshi Sonoda und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Cord Blood Stem Cell Transplantation, CHARGE Syndrome, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: The Health and Labor Sciences Research grants (Research on Intractable Diseases) from the Ministry of Health, Labor and Welfare of Japan, Japan Society for the Promotion of Science KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

CHARGE syndrome is a congenital malformation syndrome caused by heterozygous mutations in the CHD7 gene. Severe combined immunodeficiency (SCID) arises from congenital athymia called CHARGE/complete DiGeorge syndrome. While cultured thymus tissue implantation (CTTI) provides an immunological cure, hematopoietic cell transplantation (HCT) is an alternative option for immuno‐reconstitution of affected infants. We aimed to clarify the clinical outcomes of patients with athymic CHARGE syndrome after HCT.

Methods

We studied the immunological reconstitution and outcomes of four patients who received non‐conditioned unrelated donor cord blood transplantation (CBT) at Kyushu University Hospital from 2007 to 2022. The posttransplant outcomes were compared with the outcomes of eight reported patients.

Results

Four index cases received CBT 70–144 days after birth and had no higher than grade II acute graft‐versus‐host disease. One infant was the first newborn‐screened athymic case in Japan. They achieved more than 500/μL naïve T cells with balanced repertoire 1 month post transplant, and survived more than 12 months with home care. Twelve patients including the index cases received HCT at a median 106 days after birth (range: 70–195 days). One‐year overall survival rate was significantly higher in patients who underwent non‐conditioned HCT than in those who received conditioned HCT (100% vs. 37.5%, p = .02). Nine patients died, and the major cause of death was cardiopulmonary failure.

Conclusions

Athymic infants achieved a prompt reconstitution of non‐skewing naïve T cells after non‐conditioned CBT that led to home care in infancy without significant infections. Non‐conditioned CBT is a useful bridging therapy for newborn‐screened cases toward an immunological cure by CTTI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cord Blood Stem Cell TransplantationCHARGE SyndromeGraft vs Host DiseaseHematopoietic Stem Cell TransplantationImmunologic Deficiency SyndromesInfantInfant, NewbornHumansInfection ControlThymus Gland

Stichwörter der Autor:innen

CHARGE/complete DiGeorge syndromeT-cell reconstitutioncultured thymus tissue implantationhematopoietic cell transplantation

Autor:innen und Institutionen

  • Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Research Center for Environment and Developmental Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, Japan.
  • Department of Pediatrics, Juntendo University, Urayasu Hospital, Chiba, Japan.
  • Division of Neonatology, Perinatal Center, Kumamoto City Hospital, Kumamoto, Japan.
  • Department of Pediatrics, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.

Förderung

  • The Health and Labor Sciences Research grants (Research on Intractable Diseases) from the Ministry of Health, Labor and Welfare of Japan
  • Japan Society for the Promotion of Science KAKENHI

Zitieren

APA

Sonoda, M., Ishimura, M., Inoue, H., Eguchi, K., Ochiai, M., Sakai, Y., Doi, T., Suzuki, K., Inoue, T., Mizukami, T., Nakamura, K., Takada, H., & Ohga, S. (2024). Non‐conditioned cord blood transplantation for infection control in athymic CHARGE syndrome. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30809

Vancouver

Sonoda M, Ishimura M, Inoue H, Eguchi K, Ochiai M, Sakai Y, et al. Non‐conditioned cord blood transplantation for infection control in athymic CHARGE syndrome. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30809

BibTeX
@article{Sonoda2024,
  author = {Sonoda, Motoshi and Ishimura, Masataka and Inoue, Hirosuke and Eguchi, Katsuhide and Ochiai, Masayuki and Sakai, Yasunari and Doi, Takehiko and Suzuki, Kyoko and Inoue, Takeshi and Mizukami, Tomoyuki and Nakamura, Kimitoshi and Takada, Hidetoshi and Ohga, Shouichi},
  title = {Non‐conditioned cord blood transplantation for infection control in athymic CHARGE syndrome},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  doi = {10.1002/pbc.30809}
}
Kostenlos starten →